INFI - Infinity Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $2.93. This is a potential upside of $2.93 (0%) from yesterday's end of day stock price of $0.

Infinity Pharmaceuticals's activity chart (see below) currently has 38 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.78% with an average time for these price targets to be met of 84.89 days.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 24-Feb-2023. First documented stock forecast 04-Sep-2014.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 24-Feb-2023

$3

2 years 10 months 16 days ago
(24-Feb-2023)

0/4 (0%)

$2.38 (383.87%)

Hold

Since 16-Nov-2022

$1.5

$1.5 (0.00%)

$3

3 years 1 months 24 days ago
(16-Nov-2022)

0/6 (0%)

$0.85 (130.77%)

Buy

Since 17-Mar-2021

$12

3 years 4 months 28 days ago
(12-Aug-2022)

0/1 (0%)

$8.8 (275.00%)

Buy

Since 07-May-2015

$4

$4 (0.00%)

$12

3 years 9 months 10 days ago
(30-Mar-2022)

0/3 (0%)

$2.87 (253.98%)

Hold

$6

$5.98 (29900.00%)

4 years 5 months 7 days ago
(02-Aug-2021)

0/1 (0%)

$3.07 (104.78%)

Show more analysts

Please expand the browser size to see the chart

What is INFI (Infinity Pharmaceuticals) average time for price targets to be met?

On average it took 84.89 days on average for the stock forecasts to be realized with a an average price target met ratio 27.78

Which analyst has the current highest performing score on INFI (Infinity Pharmaceuticals) with a proven track record?

ANDREW D'SILVA

Which analyst has the current lower performing score on INFI (Infinity Pharmaceuticals) with a proven track record?

IAN SOMAIYA

Which analyst has the most public recommendations on INFI (Infinity Pharmaceuticals)?

Andrew D'silva has 6 price targets and 5 ratings on INFI

Which analyst is the currently most bullish on INFI (Infinity Pharmaceuticals)?

Ian Somaiya with highest potential upside - $13

Which analyst is the currently most reserved on INFI (Infinity Pharmaceuticals)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?